(Q57216076)
Statements
PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer (English)
0 references
March 2008
0 references
53
0 references
3
0 references
547-53
0 references